Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Tuesday's Intraday Session

Author: Benzinga Insights | September 02, 2025 01:06pm

Gainers

  • CARISMA Therapeutics (NASDAQ:CARM) shares increased by 108.5% to $0.45 during Tuesday's regular session. The market value of their outstanding shares is at $8.9 million.
  • Mineralys Therapeutics (NASDAQ:MLYS) shares rose 86.36% to $28.85. The company's market cap stands at $1.0 billion.
  • Cytokinetics (NASDAQ:CYTK) stock rose 39.0% to $49.11. The company's market cap stands at $4.2 billion.
  • United Therapeutics (NASDAQ:UTHR) stock rose 34.82% to $410.88. The company's market cap stands at $13.7 billion.
  • Ionis Pharmaceuticals (NASDAQ:IONS) shares moved upwards by 32.66% to $56.56. The company's market cap stands at $6.7 billion.
  • Relmada Therapeutics (NASDAQ:RLMD) shares moved upwards by 25.89% to $1.41. The company's market cap stands at $37.1 million.

Losers

  • Celularity (NASDAQ:CELU) shares fell 36.0% to $2.52 during Tuesday's regular session. The market value of their outstanding shares is at $94.3 million. As per the press release, Q2 earnings came out 2 days ago.
  • Tectonic Therapeutic (NASDAQ:TECX) stock decreased by 32.52% to $17.24. The market value of their outstanding shares is at $477.9 million.
  • ALT5 Sigma (NASDAQ:ALTS) stock decreased by 28.88% to $5.61. The company's market cap stands at $958.2 million.
  • Purple Biotech (NASDAQ:PPBT) shares decreased by 23.87% to $1.51. The market value of their outstanding shares is at $5.2 million.
  • ImmunoPrecise Antibodies (NASDAQ:IPA) shares declined by 18.57% to $1.93. The market value of their outstanding shares is at $109.3 million.
  • Canopy Growth (NASDAQ:CGC) stock fell 15.9% to $1.51. The market value of their outstanding shares is at $561.5 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: ALTS CARM CELU CGC CYTK IONS IPA MLYS PPBT RLMD TECX UTHR

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist